These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4082118)

  • 21. Anomalous antidiuretic activity of antidiuretic hormone antagonists.
    Kinter LB; Caltabiano S; Huffman WF
    Biochem Pharmacol; 1993 May; 45(9):1731-7. PubMed ID: 8494530
    [No Abstract]   [Full Text] [Related]  

  • 22. The influence of oxytocin, vasopressin and their analogues on progesterone and testosterone production by porcine granulosa cells in vitro.
    Sirotkin AV; Nitray J
    Ann Endocrinol (Paris); 1992; 53(1):32-6. PubMed ID: 1444177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of nociceptive thresholds by vasopressin in the Brattleboro and normal rat.
    Bodnar RJ; Wallace MM; Kordower JH; Nilaver G; Cort J; Zimmerman EA
    Ann N Y Acad Sci; 1982; 394():735-9. PubMed ID: 6960791
    [No Abstract]   [Full Text] [Related]  

  • 24. Properties of the factor VIII after DDAVP (1-deamino-8-D-arginine vasopressin) infusion in normal subjects.
    Takahashi H; Itoh M; Kobayashi I; Sakuragawa N; Shibata A
    Tohoku J Exp Med; 1980 Oct; 132(2):133-40. PubMed ID: 6777902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DDAVP (1-desamino-8-D-arginine vasopressin): an antagonist of the pressor action of endogenous vasopressin?
    Derkx FH; Man in 't Veld AJ; Jones R; Reid JL; Schalekamp MA
    J Hypertens Suppl; 1983 Dec; 1(2):58-61. PubMed ID: 6400119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of deamino-8-D-arginine vasopressin on urinary prostaglandins E2 and F2 alpha excretion.
    Walker L; Frölich JC
    Adv Prostaglandin Thromboxane Res; 1980; 7():1107-9. PubMed ID: 7369023
    [No Abstract]   [Full Text] [Related]  

  • 27. Vasopressin analogues and spatial short-term memory in rats.
    Buresová O; Skopková J
    Peptides; 1980; 1(3):261-3. PubMed ID: 7232229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desmopressin and sheared platelets: a test.
    O'Brien JR; Green PJ; Salmon GP
    Lancet; 1988 Mar; 1(8586):655. PubMed ID: 2894592
    [No Abstract]   [Full Text] [Related]  

  • 29. L-NAME antagonizes vasopressin V2-induced vasodilatation in dogs.
    Liard JF
    Am J Physiol; 1994 Jan; 266(1 Pt 2):H99-106. PubMed ID: 8304528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasopressin inhibits the adenylate cyclase activity of human platelet particulate fraction through V1-receptors.
    Vanderwel M; Lum DS; Haslam RJ
    FEBS Lett; 1983 Dec; 164(2):340-4. PubMed ID: 6317457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasminogen activator response after DDAVP: a clinico-pharmacological study.
    Mannucci PM; Rota L
    Thromb Res; 1980 Oct; 20(1):69-76. PubMed ID: 7193918
    [No Abstract]   [Full Text] [Related]  

  • 32. Antihaemophilic effect of vasopressin, deamino-(D-arginine8)-vasopressin and adrenaline in sheep: proposal for an in vivo assay system.
    Heiniger J; Kissling-Albrecht L; Neuenschwander S; Rösli R; Pliska V
    Br J Pharmacol; 1988 Jun; 94(2):279-81. PubMed ID: 3134968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brain water accumulation after the central administration of vasopressin.
    Dóczi T; Szerdahelyi P; Gulya K; Kiss J
    Neurosurgery; 1982 Sep; 11(3):402-7. PubMed ID: 7133357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural requirements for activation of vasopressin-sensitive adenylate cyclase, hormone binding, and antidiuretic actions: effects of highly potent analogues and competitive inhibitors.
    Butlen D; Guillon G; Rajerison RM; Jard S; Sawyer WH; Manning M
    Mol Pharmacol; 1978 Nov; 14(6):1006-17. PubMed ID: 732809
    [No Abstract]   [Full Text] [Related]  

  • 35. Effect of des-amino-D-arginine vasopressin (DDAVP) on plasma levels of platelet and endothelial cell release products.
    D'Angelo A; Capitanio A; Smith JB; Valsecchi C; Mannucci PM
    Thromb Haemost; 1983 Feb; 49(1):64-5. PubMed ID: 6687766
    [No Abstract]   [Full Text] [Related]  

  • 36. Desensitization of renal vasopressin-stimulated adenylate cyclase by a vasopressor and antidiuretic antagonist, [1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid),2-(O-ethyl)-D-tyrosine, 4-valine]arginine vasopressin.
    Chang P; Kimura K
    Biochem Biophys Res Commun; 1987 Apr; 144(2):770-8. PubMed ID: 3579941
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of vasopressin on noradrenaline-induced cyclic AMP accumulation in rat brain slices.
    Hamburger-Bar R; Newman ME
    Pharmacol Biochem Behav; 1985 Feb; 22(2):183-7. PubMed ID: 2984701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotension during vasopressin receptor blockade: role of V2 receptors and sympathetic nervous system.
    Brooks VL; Hatton DC
    Am J Physiol; 1991 Jun; 260(6 Pt 2):H1878-87. PubMed ID: 1829332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of arginine-8-vasopressin and 1-deamino-8-D-arginine-vasopressin on ACTH secretion in rats.
    László FA; Janáky T; Julesz J; Kárteszi M; Makara GB; Stark E
    Endocrinol Exp; 1983 Jun; 17(2):133-6. PubMed ID: 6309504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vasopressin antagonism in the squirrel monkey (Saimiri sciureus).
    Kinter LB; Churchill S; Stassen FL; Moore M; Huffman W
    J Pharmacol Exp Ther; 1987 Jun; 241(3):797-803. PubMed ID: 3598903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.